Recent Finacing
Recent Raise
Capstan builds targeted lipid nanoparticles conjugated with protein binders to deliver mRNA or gene‑editing payloads to specific cell types, including in vivo CAR‑T engineering of CD8 T cells.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Capstan Therapeutics.
